NeonMind Biosciences Inc: NeonMind Appoints Dr. Frank Russo to Lead Development of Music-Based Program for Psilocybin Clinical Trials
NeonMind Biosciences Inc. (
CSE: NEON) (
NeonMind ) a company conducting research into the potentially therapeutic uses of compounds found in psychedelic mushrooms, is pleased to announce that it has added Frank Russo as an advisor and consultant to assist the Company in selecting or developing music playlists for its clinical trials or for use with treatments to support optimum mental health.
NeonMind Engages Music Expert Dr. Frank Russo
To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/7646/72039 img1a.jpg